日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Research landscape of experiments on global change effects on mycorrhizas

全球变化对菌根影响实验研究现状

期刊:New Phytologist
影响因子:8.1
doi:10.1111/nph.70452
Lehmann, Anika; Tang, Bo; Rongstock, Rebecca; Sommerburg, Alexa; Chramova, Natalja; Ergül, Kevser; Heydebreck, Katharina; Quiram, Nasrin; Maaß, Stefanie; Leifheit, Eva F; Rillig, Matthias C
发表日期：2025
文献求助 收藏

First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study

阿维鲁单抗一线治疗转移性默克尔细胞癌患者：JAVELIN Merkel 200 研究 B 部分的 4 年随访

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103461
D'Angelo, S P; Lebbé, C; Mortier, L; Brohl, A S; Fazio, N; Grob, J-J; Prinzi, N; Hanna, G J; Hassel, J C; Kiecker, F; von Heydebreck, A; Güzel, G; Nghiem, P
细胞生物学
肿瘤
Mer
肿瘤免疫
发表日期：2024
文献求助 收藏

Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial

Avelumab治疗晚期不可切除间皮瘤患者的疗效和安全性：JAVELIN实体瘤试验的1b期结果

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2018.5428
Hassan, Raffit; Thomas, Anish; Nemunaitis, John J; Patel, Manish R; Bennouna, Jaafar; Chen, Franklin L; Delord, Jean-Pierre; Dowlati, Afshin; Kochuparambil, Samith T; Taylor, Matthew H; Powderly, John D; Vaishampayan, Ulka N; Verschraegen, Claire; Grote, Hans Juergen; von Heydebreck, Anja; Chin, Kevin; Gulley, James L
发表日期：2019
文献求助 收藏

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial

Avelumab治疗复发或难治性卵巢癌患者的疗效和安全性：JAVELIN实体瘤试验的1b期结果

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2018.6258
Disis, Mary L; Taylor, Matthew H; Kelly, Karen; Beck, J Thaddeus; Gordon, Michael; Moore, Kathleen M; Patel, Manish R; Chaves, Jorge; Park, Haeseong; Mita, Alain C; Hamilton, Erika P; Annunziata, Christina M; Grote, Hans Juergen; von Heydebreck, Anja; Grewal, Jaspreet; Chand, Vikram; Gulley, James L
肿瘤
肿瘤免疫
卵巢癌
发表日期：2019
文献求助 收藏

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

Avelumab治疗既往接受过治疗的转移性黑色素瘤患者：JAVELIN实体瘤试验的1b期结果

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-018-0459-y
Keilholz, Ulrich; Mehnert, Janice M; Bauer, Sebastian; Bourgeois, Hugues; Patel, Manish R; Gravenor, Donald; Nemunaitis, John J; Taylor, Matthew H; Wyrwicz, Lucjan; Lee, Keun-Wook; Kasturi, Vijay; Chin, Kevin; von Heydebreck, Anja; Gulley, James L
黑色素瘤
发表日期：2019
文献求助 收藏

Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial

Avelumab治疗既往接受过治疗的转移性肾上腺皮质癌患者：JAVELIN实体瘤试验的1b期结果

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-018-0424-9
Le Tourneau, Christophe; Hoimes, Christopher; Zarwan, Corrine; Wong, Deborah J; Bauer, Sebastian; Claus, Rainer; Wermke, Martin; Hariharan, Subramanian; von Heydebreck, Anja; Kasturi, Vijay; Chand, Vikram; Gulley, James L
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2018
文献求助 收藏

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

在接受过治疗的转移性默克尔细胞癌患者中，经过≥1年的随访，avelumab 的疗效得到了更新：JAVELIN Merkel 200，一项 II 期临床试验

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-017-0310-x
Kaufman, Howard L; Russell, Jeffery S; Hamid, Omid; Bhatia, Shailender; Terheyden, Patrick; D'Angelo, Sandra P; Shih, Kent C; Lebbé, Céleste; Milella, Michele; Brownell, Isaac; Lewis, Karl D; Lorch, Jochen H; von Heydebreck, Anja; Hennessy, Meliessa; Nghiem, Paul
细胞生物学
肿瘤
Mer
肿瘤免疫
发表日期：2018
文献求助 收藏

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

阿维鲁单抗（一种抗PD-L1抗体）治疗局部晚期或转移性乳腺癌患者的疗效：一项1b期JAVELIN实体瘤研究

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-017-4537-5
Dirix, Luc Y; Takacs, Istvan; Jerusalem, Guy; Nikolinakos, Petros; Arkenau, Hendrik-Tobias; Forero-Torres, Andres; Boccia, Ralph; Lippman, Marc E; Somer, Robert; Smakal, Martin; Emens, Leisha A; Hrinczenko, Borys; Edenfield, William; Gurtler, Jayne; von Heydebreck, Anja; Grote, Hans Juergen; Chin, Kevin; Hamilton, Erika P
PD-L1
肿瘤
肿瘤免疫
乳腺癌
发表日期：2018
文献求助 收藏

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Avelumab 用于转移性或局部晚期既往接受过治疗的实体瘤（JAVELIN 实体瘤）：一项 1a 期、多队列、剂量递增试验

期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(17)30239-5
Heery, Christopher R; O'Sullivan-Coyne, Geraldine; Madan, Ravi A; Cordes, Lisa; Rajan, Arun; Rauckhorst, Myrna; Lamping, Elizabeth; Oyelakin, Israel; Marté, Jennifer L; Lepone, Lauren M; Donahue, Renee N; Grenga, Italia; Cuillerot, Jean-Marie; Neuteboom, Berend; Heydebreck, Anja von; Chin, Kevin; Schlom, Jeffrey; Gulley, James L
发表日期：2017
文献求助 收藏

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

阿维鲁单抗治疗化疗难治性转移性默克尔细胞癌患者：一项多中心、单组、开放标签的 II 期试验

期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(16)30364-3
Kaufman, Howard L; Russell, Jeffery; Hamid, Omid; Bhatia, Shailender; Terheyden, Patrick; D'Angelo, Sandra P; Shih, Kent C; Lebbé, Céleste; Linette, Gerald P; Milella, Michele; Brownell, Isaac; Lewis, Karl D; Lorch, Jochen H; Chin, Kevin; Mahnke, Lisa; von Heydebreck, Anja; Cuillerot, Jean-Marie; Nghiem, Paul
细胞生物学
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏